QSAM Biosciences
  • About
    • Our Story
    • Leadership
    • Contact Us
  • Technology
    • CycloSam®
    • Publications
  • Pipeline
    • Metastatic Bone Cancers
    • Osetosarcoma/Ewing’s Sarcoma
    • Bone Marrow Ablation
  • Investors
    • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Forward-Looking Statements
    • Code of Ethics
  • Investors
  • About
  • Technology
  • Pipeline
  • Investors

Quote

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

  • Stock Data

  • Quote
  • Charts
  • Historical Data
  • Email Alerts
  • Contacts
  • RSS News Feed
Return to main site

Contact Us

  • info@qsambio.com
  • (512) 343-4558
  • 9442 N Capital of Texas Hwy, Plaza 1, Ste 500 Austin, TX 78759

© Copyright 2023 QSAM Biosciences, Inc. | All Rights Reserved. | Privacy Policy | Terms 
Cyclosam® is a registered trademark of IGL Pharma, Inc., a development partner of QSAM Therapeutics, Inc.